GLP-1 Coverage Guide is a private website. We are not Medicare, the Centers for Medicare & Medicaid Services (CMS), or any government agency, and we are not affiliated with or endorsed by them.
Text size:

Medicare Advantage vs. standalone Part D for the Bridge

Published by GLP-1 Coverage Guide · Updated · No clinician review is credited for this page.

Short answer: An eligible standalone PDP or Medicare Advantage coordinated-care drug plan can satisfy the Bridge’s plan requirement. Other plan types may be excluded unless a separate standalone PDP applies. The Bridge copay and central authorization process do not replace your plan’s own benefits or the remaining eligibility requirements.

Sources for the coverage rules are listed below. An update date marks a revision; it does not imply a sitewide medical review.

Plan type matters

CMS includes standalone PDPs and Medicare Advantage coordinated-care plans with drug coverage: HMO, HMO-POS, and local or regional PPO plans. Certain other arrangements, including private fee-for-service, cost, health care prepayment, PACE, fallback and religious fraternal benefit plans, are excluded unless a separate standalone PDP applies. Confirm the exact plan type with the plan or Medicare.

Compare Bridge rules and plan benefits separately

For an eligible Bridge prescription, CMS sets the $50 drug copay, covered presentations and central prior-authorization process. The demonstration operates outside the Part D benefit. The plan’s own formulary, premiums, provider access and other benefits remain separate matters to compare.

For prescriptions routed to regular Part D, including applicable diabetes, sleep-apnea, MASH or cardiovascular-risk-reduction indications, check the plan’s formulary, authorization rules and costs. Neither a plan label nor a diagnosis guarantees that a particular prescription is covered.

Confirm continued eligibility before switching

Changing plans is not automatically safe for Bridge access. CMS says that moving to an ineligible plan type can cause a Bridge refill rejection, even after prior authorization was approved. Confirm that the new coverage is effective and is an eligible type, and check your other prescriptions, clinicians and costs before deciding.

A later GLP-1 fill through Part D can also end Bridge eligibility. Ask the pharmacy for the exact reason if a refill is rejected rather than assuming the authorization restarted or the copay changed.

Correction — October 6, 2026

Earlier text called the Bridge plan-agnostic and described plan switching without stating the eligible-plan condition. Those statements were too broad: CMS excludes certain plan types and says that switching into an ineligible type can end Bridge access.

Take the Medicare eligibility check →

Common questions

Does an MA-PD label prove my plan qualifies?

No. Confirm the exact type. CMS includes coordinated-care MA drug plans and excludes certain other arrangements unless a separate standalone PDP applies.

What if my Part D plan already paid for a weight-management GLP-1 in 2026?

A GLP-1 paid through Part D in 2026 rules out Bridge access for 2026, including supplemental plan coverage for weight management. Continue checking coverage through your plan; CMS has not determined the 2027 lookback period.

If I switch plans, does my Bridge authorization guarantee a refill?

No. CMS says a change to an ineligible plan type can cause a refill rejection even after Bridge approval. Confirm the new plan type, effective coverage and continued eligibility before relying on a refill.

Next steps

Related

Sources: CMS: eligible plan types and clinical criteria · CMS: refill rejection after a plan change · CMS: supplemental coverage and prior Part D use